|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets [abstract] | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash (Note 25) | |||||||||
| Trade and other receivables | |||||||||
| Prepaid expenses and other | |||||||||
| Risk management assets (Note 14 and 15) | |||||||||
| Inventory (Note 16) | |||||||||
| Assets held for sale (Note 4 and 18) | |||||||||
| Current assets | |||||||||
| Non-current assets | |||||||||
| Investments (Note 9) | |||||||||
| Long-term portion of finance lease receivables | |||||||||
| Risk management assets non-current | |||||||||
| Property, plant and equipment (Note 19) | |||||||||
| Cost | |||||||||
| Accumulated depreciation | |||||||||
| Total property, plant and equipment (Note 19) | |||||||||
| Right-of-use assets | |||||||||
| Intangible assets | |||||||||
| Cost | |||||||||
| Accumulated depreciation | |||||||||
| Total intangible assets | |||||||||
| Total goodwill | |||||||||
| Deferred income tax assets (Note 11) | |||||||||
| Long-term financial assets (Note 14) | |||||||||
| Other assets (Note 23) | |||||||||
| Total assets | |||||||||
| Liabilities [abstract] | |||||||||
| Current liabilities | |||||||||
| Bank overdraft | |||||||||
| Cost | |||||||||
| Total bank overdraft | |||||||||
| Accounts payable, accrued liabilities and other current liabilities (Note 13) | |||||||||
| Cost | |||||||||
| Total accounts payable, accrued liabilities and other current liabilities (Note 13) | |||||||||
| Current portion of decommissioning and other provisions (Note 24) | |||||||||
| Risk management liabilities (Note 14 and 15) | |||||||||
| Current portion of contract liabilities | |||||||||
| Income taxes payable | |||||||||
| Dividends payable (Note 28 and 29) | |||||||||
| Cost | |||||||||
| Total dividends payable (Note 28 and 29) | |||||||||
| Exchangeable securities (Note 26) | |||||||||
| Contingent consideration payable (Note 4 and 7) | |||||||||
| Current portion of long-term debt and lease liabilities (Note 25) | |||||||||
| Current liabilities | |||||||||
| Non-current liabilities | |||||||||
| Credit facilities, long-term debt and lease liabilities (Note 25) | |||||||||
| Exchangeable securities | |||||||||
| Cost | |||||||||
| Total exchangeable securities | |||||||||
| Decommissioning and other provisions (Note 24) | |||||||||
| Deferred income tax liabilities (Note 11) | |||||||||
| Risk management liabilities (Note 14 and 15) | |||||||||
| Contract liabilities (Note 5) | |||||||||
| Defined benefit obligation and other long-term liabilities (Note 27) | |||||||||
| Liabilities | |||||||||
| Cost | |||||||||
| Total liabilities | |||||||||
| Equity | |||||||||
| Issued capital | |||||||||
| Common shares | |||||||||
| Preferred shares | |||||||||
| Common shares (Note 28) | |||||||||
| Preferred shares (Note 29) | |||||||||
| Contributed surplus | |||||||||
| Deficit | |||||||||
| Accumulated other comprehensive (loss) income (Note 30) | |||||||||
| Equity attributable to shareholders | |||||||||
| Non-controlling interests (Note 12) | |||||||||
| Total equity | |||||||||
| Total liabilities and equity | |||||||||
Loading...
